The introduction of sericin protein in the synthesis of PBR can respond to the weak acidity of the tumor microenvironment and metal matrix proteases (MMP-9), leading to PBR accumulation in mice and decomposing into ions and discrete nanoparticles, which are ultimately cleared from the body through renal clearance, effectively addressing their biosafety issues. The gene discussed is MMP9; the disease is neoplasm.